Our study revealed several key genes with high degrees involved in the subnetwork, including CD274, CD20, and FASLG that have been widely used in clinical tumor treatment, and they were positively associated with poor prognosis in CRC. This evidence concerns the gene FASLG and colorectal carcinoma.